Can Semaglutide Cause Diarrhoea? What the Trial Data and NHS Guidance Say

What the trial data actually recorded about diarrhoea

The STEP 1 trial (the pivotal 68-week study of semaglutide 2.4 mg for weight management, published in the New England Journal of Medicine) found that gastrointestinal events were the most frequent adverse effects in the semaglutide group. Diarrhoea was among those reported at notably higher rates than in the placebo arm. The NHS medicines page for semaglutide lists diarrhoea as a common side effect, meaning it is reported by roughly one in ten people or more. It is worth being clear about what that means in practice: common does not mean inevitable, and for many people it remains mild enough that it does not disrupt daily life.

The mechanism is fairly well understood. Semaglutide slows the rate at which food moves through the stomach and upper gut. During the adjustment period, particularly when the dose steps up, the digestive system can overcompensate in the lower gut, leading to looser stools. This is the same general pattern seen with other GLP-1 medicines, and it is why the titration schedule exists — giving the body time to adapt at each level before moving to the next.

Most episodes are time-limited. They tend to cluster around dose changes rather than persisting at a constant level throughout treatment. That pattern is consistent across both the injection and the newer oral form of semaglutide for weight management, and if you want to understand more about whether semaglutide can give you diarrhoea and how likely that is, we cover the question in detail. If you want a closer look at how this plays out specifically with Wegovy, the Wegovy side effects overview covers the broader picture.

Practical steps that can reduce the severity

If diarrhoea does appear, several straightforward measures can ease it. Eating smaller, lower-fat meals reduces the burden on a gut that is already slowing down. Fatty or heavily spiced food tends to worsen GI symptoms on GLP-1 treatment across the board. Staying well hydrated is the single most important practical step: diarrhoea losses fluids and salts faster than most people realise, and even mild dehydration amplifies fatigue and headaches that sometimes accompany treatment.

Some people find that taking their weekly injection on a day when they can rest the following morning is helpful, though this is a pattern observation, not a clinical instruction; timing should be discussed with your prescriber. Alcohol can irritate the gut independently and may intensify GI symptoms while the body is adjusting to semaglutide. These are the kinds of practical questions our prescribers discuss as part of an ongoing review, not just at the point of approval. If you are thinking about starting treatment and want to understand how semaglutide causes diarrhoea at the mechanistic level, the explanation of why Wegovy affects the gut goes into more detail.

It is also worth knowing that diarrhoea early in treatment does not predict how the rest of treatment will go. Many people who have a difficult first few weeks find the next dose level much easier. Giving it time, while keeping your prescriber informed, is usually the right approach, not stopping abruptly.

When semaglutide-related diarrhoea means getting medical help

Most diarrhoea on semaglutide is an inconvenience rather than a danger. There are specific situations, though, where it needs prompt attention. Contact your prescriber or NHS 111 if diarrhoea is severe, lasts more than a few days without improving, or is accompanied by signs of dehydration: dizziness when standing, very dark urine, or noticeably reduced urination. Severe fluid loss can put strain on the kidneys, and anyone taking medicines that already affect kidney function needs to be especially aware of this.

Seek urgent medical help if diarrhoea is accompanied by severe, persistent abdominal pain, particularly pain that radiates through to the back. The MHRA issued a Drug Safety Update in January 2026 specifically highlighting acute pancreatitis as an infrequent but serious risk with GLP-1 medicines; stomach pain that does not settle is the key warning sign. That is different from the cramping that sometimes goes alongside loose stools; the distinction is persistence and severity. If you are specifically on Wegovy and want to understand whether Wegovy can cause diarrhoea and what that looks like compared with a more serious symptom, the detailed guide to Wegovy and diarrhoea also covers when symptoms suggest something beyond a routine GI episode.

Allergic reactions are rare but possible: facial swelling, difficulty breathing or a widespread rash after injection all need emergency attention. Any side effect you consider serious or unexpected (including if semaglutide causes diarrhoea that concerns you) can be reported to the MHRA through the Yellow Card reporting service, which helps build the national safety picture for medicines in real-world use. Your report genuinely contributes to that process.

How a clinical review shapes your experience of side effects

One thing people tell our prescribers they wish they had known earlier: side-effect severity is not random. Your starting dose, the rate of titration, your other medicines and your general health all influence how your gut responds. A thorough clinical assessment before treatment begins (and at every repeat) means a prescriber can flag in advance if you have factors that raise the likelihood of GI effects, or that make dehydration a particular concern.

If diarrhoea is already affecting you and you are partway through treatment, that is also something to raise rather than manage alone. Slowing the titration, adjusting timing, or reviewing the full medicines list are all options a prescriber can consider. Our clinical team's approach to this is described on the clinical team page, and the Wegovy treatment overview sets out how semaglutide fits into a supervised weight-management programme. If you have not yet started and want to understand the full range of weight-loss treatment options, our prescribers discuss suitability and exactly this kind of side-effect profile as part of every free consultation.